Research
Dalhousie’s new Killam Memorial Chairs push boundaries in health, humanities, and agriculture
Four Dalhousie researchers are set to embark on the next chapter of their scholarly careers with strong momentum behind them as Killam Memorial Chairs. Read more.
Featured News
Monday, July 20, 2026
A landmark Dalhousie-led study could reshape post-surgical care, showing a simpler approach after joint replacement may deliver comparable outcomes while lowering health-care costs.
Thursday, June 25, 2026
A reimagined OpenThink cohort moves beyond blogging, testing podcasts and social media to broaden impact, connect with new audiences, and amplify how Dal research informs public dialogue and policy.
Thursday, June 18, 2026
Dalhousie robotics and underwater acoustics researcher Dr. Mae Seto is working with Defence Research & Development Canada to develop intelligent autonomous sensing systems that can extend the reach of the Canadian Armed Forces in the Arctic and help Canada protect its sovereignty in remote, harsh maritime environments.
Archives - Research
Tuesday, October 18, 2016
Postdoc Brendan Haley is researching hydroelectric power and other renewable energy sources, exploring how Canada can maximize its hydroelectric advantage to promote low-carbon systems of innovation.
Tuesday, October 4, 2016
The Maritimes have the highest rates of inflammatory bowel disease in the world. Now, Dal's Dr. Tony Otley is set to lead the pediatric component of a five-year, $36-million pan-Canadian gastrointestinal research network.
Thursday, September 29, 2016
Bioethicist Françoise Baylis is this year's recipient of the Royal Society of Canada's McNeil Medal, which celebrates outstanding promotion and communication of science to students and the public.
Thursday, September 15, 2016
Stan Matwin’s MERIDIAN project, supported by CFI's Cyberinfrastructure Initiative, will help protect marine species and establish Canada as a global leader in the field of ocean acoustic data.
Tuesday, September 13, 2016
Dal researchers have developed a drug aimed at preventing a rare genetic blinding disease known as "FEVR" that affects children from birth.